Loss of INI1 expression in colorectal carcinoma is associated with high tumor grade, poor survival, BRAFV600E mutation, and mismatch repair deficiency-Reference-Cited by-同舟云学术

Loss of INI1 expression in colorectal carcinoma is associated with high tumor grade, poor survival, BRAFV600E mutation, and mismatch repair deficiency

Published:2016-09 Issue: Volume:55 Page:83-90
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Wang Jennifer,Andrici Juliana,Sioson Loretta,Clarkson Adele,Sheen Amy,Farzin Mahtab,Toon Christopher W.,Turchini John,Gill Anthony J.^ORCID

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference33 articles.

1. INI1-deficient tumors: diagnostic features and molecular genetics;Hollmann;Am J Surg Pathol,2011

2. Immunohistochemistry of INI1 expression: a new tool for old challenges in CNS and soft tissue pathology;Judkins;Adv Anat Pathol,2007

3. SWI/SNF chromatin remodeling complexes and cancer;Biegel;Am J Med Genet C: Semin Med Genet,2014

4. The role of SMARCB1/INI1 in the development of rhabdoid tumors;Roberts;Cancer Biol Ther,2009

5. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors;Biegel;Cancer Res,1999

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conventional Spinal Chordomas: Investigation of SMARCB1/INI1 Protein Expression, Genetic Alterations in SMARCB1 Gene, and Clinicopathological Features in 89 Patients;Cancers;2024-08-09

2. The role of SWI/SNF complexes in digestive system neoplasms;Medical Oncology;2024-04-17

3. Response to PD-1 inhibitor in SMARCB1‑deficient undifferentiated rectal carcinoma with low TMB, proficient MMR and BRAF V600E mutation: a case report and literature review;Diagnostic Pathology;2024-01-12

4. SMARCB1/INI1 loss in skull base conventional chordomas: a clinicopathological and molecular analysis;Frontiers in Oncology;2023-06-30

5. The management of oligometastatic disease in colorectal cancer: Present strategies and future perspectives;Critical Reviews in Oncology/Hematology;2023-06